Pharmacokinetics of dexmedetomidine in Chinese post-surgical intensive care unit patients

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 3, 2011, Pages 359-367

  Lin, L ^a   Guo, X ^b   Zhang, M Z ^a   Qu, C J ^b   Sun, Y ^a   Bai, J ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Yangpu District Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; EPHEDRINE; ESMOLOL; MIDAZOLAM; MORPHINE;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY SURFACE; BODY WEIGHT; BRADYCARDIA; CHINESE; CLINICAL ARTICLE; DRUG CLEARANCE; FEMALE; GENDER; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; LEAN BODY WEIGHT; LOADING DRUG DOSE; MALE; PLASMA CONCENTRATION-TIME CURVE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; SEDATION; TACHYCARDIA;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADULT; AGED; ANALGESICS; DEXMEDETOMIDINE; FEMALE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL;

EID: 79751493114     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2010.02392.x     Document Type: Article

References (30)

1. Virtanen R, Savola JM, Saano V, Nyman L., Characterization of the selectivity, specificity and potency of medetomidine as an alpha2 adrenoceptor agonist. Eur J pharmacol 1988; 150: 9-14.
2. Maze M, Tranquilli W., Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991; 74: 581-605.
3. Bhana N, Goa KL, McClellan KJ., Dexmedetomidine. Drugs 2000; 59: 263-8. (Pubitemid 30168513)
4. Alexander E, Sulsa GM., Dexmedetomidine use in critical care. AACN Advanced Critical Care 2008; 19: 113-20.
5. Petroz GC, Sikich N, James M, van Dyk H, Shafer SL, Schily M, Lerman J., A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006; 105: 1098-110. (Pubitemid 44808573)
6. Dyck JB, Schafer SL., Dexmedetomidine pharmacokinetics and pharmacodynamics. Anesth Pharmacol Rev 1993; 71: 108-18.
7. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL., The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 813-20. (Pubitemid 23141353)
8. Dyck JB, Maze M, Haack C, Azarnoff DL, Vuorilehto L, Shafer SL., Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 821-8. (Pubitemid 23141354)
9. Kivistö KT, Kallio A, Neuvonen PJ., Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. Eur J Clin Pharmacol 1994; 46: 345-9. (Pubitemid 24167383)
10. Talke P, Richardson CA, Scheinin M, Fisher DM., Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997; 85: 1136-42. (Pubitemid 27471539)
11. Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D., Effects of dexmedetomidine on isoflurane requirements in healthy volunteers.1 Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999; 83: 372-80. (Pubitemid 29412688)
12. Dutta S, Lal R, Karol MD, Cohen T, Ebert T., Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharmaceut Sci 2000; 89: 519-27.
13. De Wolf AM, Fragen RJ, Avram MJ, Fitzgerald PC, Rahimi-Danesh F., The pharmacokinetics of dexmedetomidine in volunteers with renal impairment. Anesth Analg 2001; 93: 1205-9. (Pubitemid 33021018)
14. Venn RM, Karol MD, Grounds RM., Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002; 88: 669-75. (Pubitemid 34498595)
15. Díaz SM, Rodarte A, Foley J, Capparelli EV., Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: preliminary study. Pediatric Crit Care Med 2007; 8: 419-24. (Pubitemid 47415293)
16. Vilo S, Rautitinen P, Kaisti K, Aantaa R, Scheinin M, Manner T, Olkkola KT., Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age. Br J Anaesth 2008; 100: 697-700. (Pubitemid 351774374)
17. Potts AL, Warman GR, Anderson BJ., Dexmedetomidine disposition in children: a population analysis. Pediatr Anesth 2008; 18: 722-30.
18. Su F, Nicolson SC, Gastonguay MR, Barrett JS, Adamson PC, Kang DS, Godinez RI, Zuppa AF., Population pharmacokinetics of dexmedetomidine in infants after open heart surgery. Anesth Analg 2010; 110: 1383-92.
19. Liu LL, Gropper MA., Postoperative analgesia and sedation in the adult intensive care unit. A guide to drug selection. Drugs 2003; 63: 755-67. (Pubitemid 36428445)
20. Lee J, Su F, Shi H, Zuppa AF., Sensitive and specific liquid chromatography-tandem mass spectrometric method for the quantitation of dexmedetomidine in pediatric plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 852: 195-201. (Pubitemid 46830109)
21. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, Billard V, Hoke JF, Moore KHP, Hermann DJ, Muir KT, Mandema JW, Shafer SL., Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: I. Model development. Anesthesiology 1997; 86: 10-23. (Pubitemid 27043998)
22. Beal SL, Sheiner LB., NONMEM users' guides: NONMEM Project Group. San Francisco, CA: University of California at San Francisco, 1998.
23. Billard V, Ganbus PL, Barr J, Minto CF, Corash L, Tessman JT, Stickney JL, Shafer SL., The pharmacokinetics of 8-methoxypsoralen following intravenous administration in humans. Br J Clin Pharm 1995; 40: 347-60.
24. Vozeh S, Maitre PO, Stanski DR., Evaluation of population (NONMEM) pharmacokinetic parameter estimates. J Pharmacokineti Biopharm 1990; 18: 161-73. (Pubitemid 20207828)
25. Drover DR, Lemmens HJM., Population pharmacokinetics and pharmacodynamics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology 1998; 89: 869-77. (Pubitemid 28463292)
26. Coetzee JF, Glen JB, Wium CA, Boshoff L., Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. Anesthesiology 1995; 82: 1328-45.
27. Mantz J., Dexmedetomidine. Drugs Today 1999; 35: 151-7. (Pubitemid 29238938)
28. Johnson JA., Predictability of the effects of race or ethnicity on pharmacokinetics of drugs. Int J Clin Pharmacol Ther 2000; 38: 53-60. (Pubitemid 30077979)
29. Hughes MA, Glass PSA, Jacobs JR., Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76: 334-41.
30. Iirola T, Laitio R, Kentala E, Aantaa R, Kurvinen JP, Scheinin M, Olkkola KT., Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report. J Med Case Reports 2010; 25: 73.